Agere Executives to Discuss Enhancing Oral Bioavailability Using Amorphous Molecular Dispersions at ExL Pharma’s “Enhancing Drug Bioavailability and Solubility” Conference

BEND, Ore. -- (BUSINESS WIRE) -- Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRO/CMO), will present, facilitate and participate in a panel discussion at ExL Pharma’s 2^nd annual conference focused on solubility and bioavailability in Boston, January 21 – 23, 2013. www.exlpharma.com/bioavailability

WHAT:				Presentation: “Enhancing Oral Bioavailability using Amorphous Molecular Dispersions: Industry Implications and Approaches for Successful cGMP Formulation Development”
				-- Formulation paradigm shift in the industry
				-- Screening Polymers & Drug Loading: Performance and Stability
				-- Small Scale Approaches to amorphous Dispersion formulations
				-- Scale-up and cGMP Manufacturing of Solid Dispersion Formulation
WHO:				Marshall Crew, CEO and Founder, Agere Pharmaceuticals, Inc.
WHEN:				Wednesday, January 23, at 3:20 p.m.
--------------------------------------------------------------------------------
WHAT:				Panel Discussion: “Advancing Amorphous Molecular Dispersions Through the Clinic: Practical Aspects of cGMP Manufacturing”
				-- Product control strategies and risk management for clinical phase products
				-- Dosage form options, excipient selections and decision making for first in human studies
				-- Design development and scale up approaches for successful cGMP manufacturing
				-- Analytical testing and regulatory considerations specific to amorphous molecular dispersions
WHO:				Marshall Crew, CEO and Founder, Agere (Moderator)
				Vince Foley, Director of Quality, Agere
				Ryan Minikis, Senior Director Formulation and Chemistry, Agere
				Ravi Shanker, Senior Research Investigator, Pfizer, Inc.
WHEN:				Tuesday, January 22, at 10 a.m.

All sessions of the conference will be held at the Omni Parker House Hotel, Boston, MA.

For more information, and to obtain a special conference discount Agere is extending to clients, please contact Agere at 541-639-8397 or www.agerepharma.com.

About Agere

Agere is a leading CRO/CMO focused on improving the oral bioavailability of insoluble APIs. The company supports clients from formulation design and development through cGMP manufacturing for Phase I, Phase IIa and Phase IIb clinical trials. Agere is expert in solid dispersion techniques including spray drying and hot melt extrusion (HME), and in a broad selection of solid dosage forms. All services are delivered on a fee-for-service basis, and every project the company undertakes is customized to serve each individual client’s requirements. Agere is located in Bend, OR. For information: www.agerepharma.com.